Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 15, 2017

Primary Completion Date

March 18, 2018

Study Completion Date

April 1, 2018

Conditions

Leishmaniasis, CutaneousLeishmania Braziliensis ComplexLeishmaniasis, AmericanLeishmaniasis; American, Cutaneous

Interventions

DRUG

Paromomycin Sulfate

topical application 2 times a day during 20 days

DRUG

Pentamidine Isethionate

3 Intralesional injections at days 1,3 and 5

OTHER

Placebo

topical application 2 times a day during 20 days

Trial Locations (2)

Hospital Local Palos Blancos, Palos Blancos

Hospital Dermatologico de Jorochito, Jorochito

All Listed Sponsors

lead

Fundacion Nacional de Dermatologia

OTHER

NCT03096457 - Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia | Biotech Hunter | Biotech Hunter